Hippocrates (შპს ჰიპოკრატე)

panel 2026-09-21Ask

as filed · GEL, thousands

Line item	2017	2018	2019	2020	2021	2022	2023	CAGR
Total Revenue	13,166	14,490	12,569	14,202	20,853	11,446	13,510	+0.4%
Total COGS	2,791	3,166	2,863	2,634	5,883	2,477	3,549	+4.1%
Gross Profit	10,376	11,324	9,706	11,568	14,970	8,969	9,962	-0.7%
Gross Margin	78.8%	78.1%	77.2%	81.5%	71.8%	78.4%	73.7%
Other Operating Income	0	0	0	0	0	0	2,149
	2,175	10,398	9,421	8,818	11,446	9,348	13,302	+35.2%
EBITDA	8,200	926	285	2,750	3,524	379	1,191	nmf
EBITDA Margin	62.3%	6.4%	2.3%	19.4%	16.9%	3.3%	8.8%
Total D&A	1,406	1,349	1,237	1,232	1,196	797	1,117	-3.8%
EBIT / Operating Income	6,795	423	952	1,517	2,327	1,176	2,309	nmf
Total Interest Expense	0	0	0	287	288	224	416	+13.2%
Total Other Income	0	54	123	881	687	766	45	-3.6%
Profit Before Tax	6,795	477	1,075	348	2,726	634	2,770	nmf
Total Income Tax	215	135	0	0	0	0	0	-37.2%
Net Profit / (Loss)	1,692	612	1,075	348	2,726	634	2,770	+8.6%
Net Margin	12.9%	4.2%	8.6%	2.5%	13.1%	5.5%	20.5%
Other Comprehensive Income	375	0	0	0	0	0	0
Total Comprehensive Income	1,317	612	1,075	348	2,726	634	2,770	+13.2%

Hippocrates